Loading...
AUROPHARMA Aurobindo Pharma Ltd Operational Disruptions Announcement
Back
rbnd
RPHR
Aurobindo Pharma Ltd
(AUROPHARMA)
Follow
FY2025 Announcement
View More
Back
rbnd
RPHR
Aurobindo Pharma Ltd
(AUROPHARMA)
Follow
FY2025 Announcement
Filing:
Announcement
Published on:
28 Apr '25
GST Order Notice
30 Apr '25
Safety Incident
28 Apr '25
Positive CHMP Opinion
26 Apr '25
USFDA Approval
23 Apr '25
Product Approval
12 Apr '25
FDA Inspection Completed
11 Apr '25
Biosimilar Study Success
9 Apr '25
Marketing Authorization Gra...
5 Apr '25
Compliance Certificate
2 Apr '25
Cautionary Email
31 Mar '25
Cautionary Notice
28 Mar '25
Acquisition Update
28 Mar '25
Share Allotment
21 Mar '25
FDA Inspection Result
19 Mar '25
Investor Plant Visit
12 Mar '25
Investor Conference
11 Mar '25
License Agreement Termination
5 Mar '25
Investor Meeting
4 Mar '25
Tax Order Received
1 Mar '25
Acquisition Completed
28 Feb '25
Investor Plant Visit
20 Feb '25
FDA Inspection Update
20 Feb '25
Investor Meeting Notice
19 Feb '25
FDA Inspection Completed
18 Feb '25
Investor Plant Visit
18 Feb '25
Investor Plant Visit
17 Feb '25
Postal Ballot Notice
14 Feb '25
Zefylti® Approval
13 Feb '25
Q3 FY25 Earnings Call
13 Feb '25
Financial Results Publication
8 Feb '25
Director Re-appointment
6 Feb '25
Stake Acquisition
6 Feb '25
Investor Presentation
6 Feb '25
Q3 Financial Results
6 Feb '25
Aquisition of Tergene
6 Feb '25
GST Demand Order
5 Feb '25
Investor Meet Scheduled
4 Feb '25
Investor Meet Scheduled
4 Feb '25
Positive Opinion Received
31 Jan '25
Tax Recovery Orders
29 Jan '25
Earnings Call Scheduled
28 Jan '25
US FDA EIR Received
28 Jan '25
Compliance Certificate
6 Jan '25
NSE Warning Letter
28 Dec '24
Biosimilar Approval
21 Dec '24
FDA Inspection Completed
17 Dec '24
Regulatory Order Received
13 Dec '24
Biosimilar Approval
13 Dec '24
Director Retirement
13 Dec '24
Equity Share Allotment
11 Dec '24
USFDA Approval
5 Dec '24
Company Clarification
4 Dec '24
Investor Meeting
29 Nov '24
New Collaboration Agreement
23 Nov '24
Equity Share Transfer
22 Nov '24
Investor Meeting Notice
21 Nov '24
Earnings Call Transcript
18 Nov '24
Investor Meeting
13 Nov '24
GMP Certification Granted
12 Nov '24
Earnings Call Recording
11 Nov '24
Financial Results Released
11 Nov '24
Financial Results Correction
10 Nov '24
Investor Presentation
9 Nov '24
Financial Results Q2FY25
9 Nov '24
Investor Meeting
7 Nov '24
Earnings Call Schedule
4 Nov '24
New Facility Inauguration
29 Oct '24
Subsidiary Acquisition
25 Oct '24
Securities Update
7 Oct '24
Share Disposal
5 Oct '24
Stake Sale Completed
5 Oct '24
FDA Approval
1 Oct '24
FDA Inspection Completion
30 Sep '24
Investor Meeting
19 Sep '24
GLS Acquisition
18 Sep '24
FDA Inspection Report
18 Sep '24
Share Transfer Notice
13 Sep '24
FDA Approval Received
11 Sep '24
GST Demand Order
29 Aug '24
Investor Meetings
28 Aug '24
Buyback Completion
26 Aug '24
Buyback Announcement
21 Aug '24
Q1 FY25 Earnings Call
16 Aug '24
FDA Warning Letter
16 Aug '24
Investor Meeting
13 Aug '24
Investor Meeting
13 Aug '24
Investor Meet
13 Aug '24
Earnings Call Audio
12 Aug '24
Financial Results Published
12 Aug '24
Investor Presentation
10 Aug '24
Strong Q1 Results
10 Aug '24
USFDA Approval
6 Aug '24
Newspaper Advertisement
6 Aug '24
FDA Inspection Status
5 Aug '24
Earnings Call
5 Aug '24
Buyback Announcement
1 Aug '24
AGM via Video
31 Jul '24
Buyback Announcement
22 Jul '24
Certificate Submission
4 Jul '24
Acquisition Announcement
28 Jun '24
External Links:
BSE
NSE
Data:
Download
AI Assistant
Close
Aurobindo Pharma Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.